Effect of Vildagliptin Versus Dapagliflozin as Add on Therapy to Metformin on Cardiovascular Risk Factors

NCT07077525 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

196

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

COMBINATION_PRODUCT: Dapagliflozin + Metformin
COMBINATION_PRODUCT: Vildagliptin + Metformin

Sponsor

Al-Azhar University

Collaborators

[object Object]